SCOTTSDALE, Ariz., June 14, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company's Board of Directors declared a quarter-end cash dividend of $0.10 per issued and outstanding share of the Company's Common Stock payable on July 31, 2012, to stockholders of record at the close of business on July 2, 2012.
Medicis is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological and aesthetic conditions. The Company is dedicated to helping patients attain a healthy and youthful appearance and self-image. Medicis has leading branded prescription products in a number of therapeutic and aesthetic categories. The Company's products have earned wide acceptance by both physicians and patients due to their clinical effectiveness, high quality and cosmetic elegance.
For more information about Medicis, please visit the Company's website at www.Medicis.com. Printed copies of the Company's complete audited financial statements are available free of charge upon request.
Medicis Kara Stancell (media) (480) 291-5454 Sean Andrews (investors) (480) 291-5854